Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
A Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01251-7.
-
Article
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
Alzheimer’s disease (AD) causes unrelenting, progressive cognitive impairments, but its course is heterogeneous, with a broad range of rates of cognitive decline1. The spread of tau aggregates (neurofibrillary ta...
-
Article
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
The past decade has witnessed hundreds of reports declaring or refuting genetic association with putative Alzheimer disease susceptibility genes. This wealth of information has become increasingly difficult to...